May 20, 2026 — Cardio Diagnostics Holdings (NASDAQ: CDIO), took the spotlight in the latest episode of The BioMedWire Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics, genetics and artificial intelligence.
May 20, 2026 — Datavault AI (NASDAQ: DVLT) announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a healthcare platform combining AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification and direct-to-consumer healthcare delivery through three concurrent transactions, including an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property and a controlling stake in Tollo Health. The combined transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions.
May 20, 2026 — University of North Carolina scientists have engineered immune cells that can destroy acute myeloid leukemia while sparing healthy blood tissue, overcoming a limitation that has plagued standard treatments, which have struggled to separate cancerous cells from normal cells. Immunologist Gianpietro Dotti and hematologist Paul Armistead directed research teams whose work appears in the journal Blood, offering an approach that may expand options for patients battling this deadly disease.
May 20, 2026 — For decades, modern cybersecurity has depended on encryption systems designed to keep sensitive information safe from hackers and cybercriminals. From online banking and email communication to medical records and cryptocurrency wallets, encryption acts as the invisible shield protecting digital life.
May 20, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
May 20, 2026 — Telomir Pharmaceuticals (NASDAQ: TELO) announced publication of peer-reviewed preclinical data in Advances in Redox Research showing that Telomir-Zn delivered dose-dependent survival improvements and multiple therapeutic benefits in a Wilson’s disease model, including reduced oxidative stress, lower hepatic copper burden and improved liver function markers. The findings support the biological activity of Telomir-Zn in Wilson’s disease and expand the company’s scientific validation as it advances its lead triple-negative breast cancer program toward Phase 1/2 clinical initiation.
May 20, 2026 — Cardio Diagnostics Holdings (NASDAQ: CDIO), took the spotlight in the latest episode of The BioMedWire Podcast, featuring CEO and Co-Founder Dr. Meesha Dogan discussing the company’s mission to improve cardiovascular disease prevention and early detection through precision medicine powered by epigenetics, genetics and artificial intelligence.
May 20, 2026 — Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.
May 20, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
May 20, 2026 — Annovis Bio (NYSE: ANVS) announced the pricing of an underwritten public offering of 7,895,000 shares of common stock and accompanying warrants to purchase up to 7,105,500 additional shares at a combined offering price of $1. 90 per share and warrant.
May 20, 2026 — Safe Pro Group (NASDAQ: SPAI) announced progress in its AI-powered threat detection collaboration with Lantronix (Nasdaq: LTRX), marking a milestone in integrating Safe Pro’s SPOTD AI technology with Lantronix’s System-on-Module platform for real-time robotic edge processing. Following a 120-day development cycle, the collaboration positions the solution for broader deployment across next-generation autonomous air, ground and sea platforms, expanding Safe Pro’s reach in defense and commercial markets through edge-native AI processing that eliminates cloud dependence.
May 20, 2026 — Scinai Immunotherapeutics (NASDAQ: SCNI) announced the appointment of Eilon Elmalem as site head of its wholly owned subsidiary Scinai Biopharma Services’ Yavne CDMO facility, effective June 14, 2026. Elmalem, who has supported the company as an external consultant for the past two years, brings more than two decades of biotechnology and pharmaceutical operations experience and will oversee site operations and engineering activities as Scinai continues expanding its contract development and manufacturing platform.
May 20, 2026 — Rail Vision (NASDAQ: RVSN, FSE: C80) announced that its majority-owned subsidiary, Quantum Transportation Ltd. , has successfully delivered a working integration layer that incorporates a publicly accessible experimental surface-code dataset from Google Quantum AI into its patent-pending quantum error correction transformer pipeline.
May 20, 2026 — This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.
May 20, 2026 — Disseminated on behalf of Lahontan Gold Corp. (TSX.
May 20, 2026 — Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage biotechnology company developing buntanetap for neurodegenerative diseases, announced a proposed underwritten public offering of common stock and accompanying warrants. The company intends to use net proceeds to support continued clinical development of buntanetap in a Phase 3 Alzheimer’s disease study, as well as for working capital and general corporate purposes.
May 19, 2026 — Virginia Governor Abigail Spanberger has approved a sweeping package of legislation passed during the 2026 General Assembly session, signing 25 measures into law that address issues ranging from criminal justice and firearm regulations to workplace rights, election procedures, and energy affordability. The newly signed measures represent part of a larger legislative effort advanced during this year’s General Assembly session, reflecting the administration’s focus on public safety, affordability, and legal reform across Virginia.
May 19, 2026 — Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.
May 19, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) is moving beyond its roots as a clinical-stage biotechnology company into the quickly expanding intersection of artificial intelligence and industrial automation. “Through two closely aligned announcements, the firm has unveiled a strategic partnership with TechForce Robotics, which positions it to commercialize a next-generation, AI-enhanced platform created for regulated pharmaceutical environments,” reads a recent article.
May 19, 2026 — Perpetuals. com (NASDAQ: PDC) announced the launch of UpsideOnly, a risk-free trading and market prediction platform that combines a proprietary AI algorithm with crowd intelligence to generate trading signals across global financial markets.
